Immune-dominated cellular heterogeneity and stromal plasticity in keloid infiltrating and hypercellular zones revealed by single-cell RNA sequencing - Scorecard - MDSpire

Immune-dominated cellular heterogeneity and stromal plasticity in keloid infiltrating and hypercellular zones revealed by single-cell RNA sequencing

  • By

  • Yuchen Cao

  • Li Duan

  • Dongxian Lin

  • Yue Liu

  • Mingzi Yang

  • Shunbing Lu

  • Yonghao Liu

  • Yuanyuan Xu

  • Lianzhao Wang

  • June 26, 2026

  • 0 min

Share

Clinical Scorecard: Characterization of Immune-Driven Cellular Diversity and Stromal Adaptability in Keloid Infiltrative and Hypercellular Regions via Single-Cell RNA Sequencing

At a Glance

CategoryDetail
ConditionKeloids
Key MechanismsImmune-stromal crosstalk driving peripheral invasion and cellular heterogeneity.
Target PopulationPatients with anterior chest keloids, aged 18-60.
Care SettingPlastic Surgery Hospital, Chinese Academy of Medical Sciences.

Key Highlights

  • Hypercellular zone dominated by myofibroblasts; infiltrating zone enriched in mononuclear phagocytes and endothelial cells.
  • Infiltrating zone fibroblasts exhibit an immunomodulatory, inflammatory phenotype.
  • Macrophages in the infiltrating zone show a type I interferon signature.
  • Langerhans cells follow a three-stage developmental trajectory influencing neutrophil and Th17 cell recruitment.
  • Endothelial cells undergo endothelial-to-mesenchymal transition at the keloid margin.

Guideline-Based Recommendations

Diagnosis

  • Keloids characterized by excessive fibroblast proliferation and ECM deposition beyond wound margins.

Management

  • Consideration of zone-specific therapies targeting hypercellular and infiltrating regions.

Monitoring & Follow-up

  • Assessment of cellular and molecular changes in keloid zones for treatment response.

Risks

  • High recurrence rates despite various therapeutic interventions.

Patient & Prescribing Data

Four female patients with anterior chest keloids.

Different keloid zones exhibit variations in treatment sensitivity and efficacy.

Clinical Best Practices

  • Utilize single-cell RNA sequencing for detailed characterization of keloid microenvironments.
  • Implement personalized treatment strategies based on keloid zone characteristics.

Related Resources & Content

Original Source(s)

Related Content